Subhadip Kundu

6PUBLICATIONS
6CO-AUTHORS
Tumour immunologyGenome structure and regulationPredictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2026
Integrated molecular and immune profiling identifies FOXA1 as a complementary co-target to MUC1 for bispecific immunotherapy in breast cancer.

|Aug 17, 2026
Navigating the cancer cell nucleus: lamins at the interface of epigenetic regulation and tumorigenesis.

|Jul 14, 2026
Integrative multi-omics analysis identifies histone methyltransferase SUV420H2 as a prognostic biomarker in clear cell renal cell carcinoma.

|Jul 14, 2026
Emerging target antigen landscape for CAR T-cell therapy in solid tumors: current advances and future directions.

|Apr 09, 2026
SUV family histone methyltransferases correlate with nuclear lamina remodeling and clinical outcome in cancer: integrative pan-cancer TCGA analysis and experimental evidence.

Subhadip Kundu, Abdur Rahmaan Akhtar, Arun Kumar

|Nov 26, 2024
Pan-cancer TCGA analysis reveals the potential involvement of B-type lamins in dysregulating chromosome segregation in human cancer.

Subhadip Kundu, Bimal Prasad Jit, Ashok Sharma

Pageof 1

Frequent Collaborators

2 joint publications

Ashok Sharma

2 joint publications

Debolina Chakraborty

1 joint publications

Bimal Prasad Jit

1 joint publications

Rupal Tripathi